Drug profile · INN
glimepiride
GLIMEPIRIDE
- US status
- approved
- Patents linked
- 0
- News articles
- 0
Quick answer
glimepiride (GLIMEPIRIDE) is an FDA-listed pharmaceutical active ingredient. Associated with Takeda Pharmaceuticals International AG. Route of administration: oral. Current US regulatory status: approved.
Key facts
INN glimepiride
Brand GLIMEPIRIDE
Route ORAL
Formulation TABLET
Originator Takeda Pharmaceuticals International AG
Frequently asked questions
What is glimepiride?
glimepiride (GLIMEPIRIDE) is an FDA-listed pharmaceutical active ingredient. Associated with Takeda Pharmaceuticals International AG. Route of administration: oral. Current US regulatory status: approved.
What is the brand name for glimepiride?
GLIMEPIRIDE is a marketed brand name for glimepiride. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of glimepiride?
glimepiride has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.